Clinical Trials on Streptococcus Pyogenes Identification in India
Total 12 results
-
GlaxoSmithKlineCompletedStreptococcus Pneumoniae | Infections, StreptococcalIndia
-
GlaxoSmithKlineCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedGroup A Beta Hemolytic Streptococcal (GAS) InfectionIndia
-
PfizerCompletedPneumococcal DiseaseIndia
-
PfizerCompletedPneumococcal DiseaseIndia
-
Macmillan Research Group UKNMP Medical Research Institute; Warwick Research ServicesUnknownRheumatic ArthritisIndia
-
PfizerActive, not recruitingPneumococcal DiseaseTaiwan, India
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedPneumococcal InfectionsIndia
-
GlaxoSmithKlineCompletedImpetigoIndia, Mexico, Netherlands, Italy, Peru
-
GlaxoSmithKlineCompletedSkin Infections, BacterialNetherlands, Costa Rica, Germany, Mexico, Canada, India, Poland, South Africa, France, Peru
-
Targanta Therapeutics CorporationCompletedWounds and Injuries | Streptococcal Infections | Abscess | Cellulitis | Staphylococcal Skin InfectionsUnited States, Australia, India, Italy, Romania, Ukraine
-
Population Health Research InstituteBayer; University of Cape TownCompletedRheumatic Heart DiseaseBotswana, Philippines, Zimbabwe, India, China, Egypt, Ethiopia, Uganda, Brazil, South Africa, Cameroon, Tanzania, Kenya, Zambia, Kazakhstan, Kyrgyzstan, Malawi, Mexico, Mozambique, Nepal, Nigeria, Pakistan, Paraguay, Rwanda, Sudan